Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Androgens can both increase and decrease hair growth in different parts of the body.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Boosting mitochondrial energy production with supplements like acetyl-L-carnitine may improve aging-related cellular function and health conditions.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Ayurvedic herbs can help manage Polycystic Ovarian Syndrome (PCOS).

Laser hair removal is the most requested cosmetic procedure and has become a scientifically-based treatment suitable for all skin types.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Men with severe hair loss may have poorer sperm quality.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Biotin may effectively treat hair loss caused by valproate medication.